Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy.
作者信息
Siontis Konstantinos C, Ommen Steve R, Geske Jeffrey B
机构信息
Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
出版信息
J Am Heart Assoc. 2019 Nov 5;8(21):e014448. doi: 10.1161/JAHA.119.014448. Epub 2019 Oct 30.
Abstract
摘要
相似文献
1
Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy.
J Am Heart Assoc. 2019 Nov 5;8(21):e014448. doi: 10.1161/JAHA.119.014448. Epub 2019 Oct 30.
2
Sex differences in hypertrophic cardiomyopathy: new insights.
Curr Opin Cardiol. 2019 May;34(3):254-259. doi: 10.1097/HCO.0000000000000612.
3
Hypertrophic Cardiomyopathy.
Circulation. 2018 Oct 2;138(14):1399-1401. doi: 10.1161/CIRCULATIONAHA.118.035932.
4
Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy.
Eur Heart J. 1983 Nov;4 Suppl F:93-104. doi: 10.1093/eurheartj/4.suppl_f.93.
5
Global and Regional Longitudinal Strain Assessment in Hypertrophic Cardiomyopathy.
Circ Cardiovasc Imaging. 2019 Aug;12(8):e009586. doi: 10.1161/CIRCIMAGING.119.009586. Epub 2019 Aug 15.
6
[Gender effect on cardiomyopathy].
G Ital Cardiol (Rome). 2012 Jun;13(6):424-31. doi: 10.1714/1073.11761.
7
Sex-differences in hypertrophic cardiomyopathy-more than 20 years of investigations.
Int J Cardiol. 2019 May 15;283:134. doi: 10.1016/j.ijcard.2018.12.080.
8
Genetics of hypertrophic and dilated cardiomyopathy.
Curr Pharm Biotechnol. 2012 Oct;13(13):2467-76. doi: 10.2174/138920112804583041.
9
[Stetho-acoustic cardiomyopathy--characteristics in cardiomyopathies studied by echocardiography].
Z Gesamte Inn Med. 1989 Aug 15;44(16):497-9.
10
No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy.
Am Heart J. 2002 Jun;143(6):E6. doi: 10.1067/mhj.2002.122514.
引用本文的文献
1
X-Chromosome-Linked miRNAs Regulate Sex Differences in Cardiac Physiology.
Circ Res. 2025 Jan 31;136(3):258-275. doi: 10.1161/CIRCRESAHA.124.325447. Epub 2024 Dec 30.
2
Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology.
Biomedicines. 2024 Nov 24;12(12):2675. doi: 10.3390/biomedicines12122675.
3
Integration analysis using bioinformatics and experimental validation on cellular signalling for sex differences of hypertrophic cardiomyopathy.
J Cell Mol Med. 2024 Nov;28(21):e70147. doi: 10.1111/jcmm.70147.
4
Sex-Associated Differences in Clinical Outcomes After Septal Reduction Therapies in Hypertrophic Cardiomyopathy.
Mayo Clin Proc. 2024 Dec;99(12):1933-1944. doi: 10.1016/j.mayocp.2024.05.026. Epub 2024 Nov 12.
5
Sex Disparities in the Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy.
CJC Open. 2024 Jun 3;6(9):1108-1115. doi: 10.1016/j.cjco.2024.05.013. eCollection 2024 Sep.
6
Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy.
Front Cardiovasc Med. 2024 Jan 11;10:1288747. doi: 10.3389/fcvm.2023.1288747. eCollection 2023.
7
Sex Differences in Mouse Cardiac Electrophysiology Revealed by Simultaneous Imaging of Excitation-Contraction Coupling.
J Cardiovasc Dev Dis. 2023 Nov 29;10(12):479. doi: 10.3390/jcdd10120479.
8
A systematic review and meta-analysis of sex differences in clinical outcomes of hypertrophic cardiomyopathy.
Front Cardiovasc Med. 2023 Dec 5;10:1252266. doi: 10.3389/fcvm.2023.1252266. eCollection 2023.
9
Age and Sex Differences in the Genetics of Cardiomyopathy.
J Cardiovasc Transl Res. 2023 Dec;16(6):1287-1302. doi: 10.1007/s12265-023-10411-8. Epub 2023 Jul 21.
10
Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta-Analysis.
J Am Heart Assoc. 2023 Jun 6;12(11):e026270. doi: 10.1161/JAHA.122.026270. Epub 2023 May 26.
本文引用的文献
1
Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
J Am Heart Assoc. 2019 Nov 5;8(21):e012041. doi: 10.1161/JAHA.119.012041. Epub 2019 Oct 30.
2
Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
Heart Vessels. 2020 Feb;35(2):214-222. doi: 10.1007/s00380-019-01492-0. Epub 2019 Sep 3.
3
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
JAMA Cardiol. 2019 Jul 1;4(7):644-657. doi: 10.1001/jamacardio.2019.1391.
4
Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
JAMA Cardiol. 2019 Mar 1;4(3):237-245. doi: 10.1001/jamacardio.2019.0084.
5
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23.
6
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).
Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.
7
Women with hypertrophic cardiomyopathy have worse survival.
Eur Heart J. 2017 Dec 7;38(46):3434-3440. doi: 10.1093/eurheartj/ehx527.
8
Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China.
PLoS One. 2014 Jul 21;9(7):e102969. doi: 10.1371/journal.pone.0102969. eCollection 2014.
9
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
Eur Heart J. 2014 Aug 7;35(30):2010-20. doi: 10.1093/eurheartj/eht439. Epub 2013 Oct 14.
10
Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2005 Aug 2;46(3):480-7. doi: 10.1016/j.jacc.2005.04.043.
Zotero 插件